Intelligent dosing delivers the right dose at the right time, for the right person – with a set dose or the flexibility of dose titration. Personalized user identification ensures that only the right person uses the device.
Just push the button to dose your medicine. The intuitive and easy-to-use handheld device dispenses micro units – making life much easier for patient groups with trouble swallowing conventional tablets and capsules.
The device connects to an ecosystem of smart health technology. A companion app can support adherence and self-monitoring. Connectivity to diagnostic systems and data creates great opportunities to improve treatment outcomes.
The most common treatment paradigm today is prescription medicine delivered as tablets or capsules in bottles or cartons. Often, they do not provide a good fit for patients or treatment goals, as pills have built in limitations.
Tablets make dose titration difficult. Swallowing can be a problem for several patient groups. Bottles cannot be locked, and tamper resistance means that containers become difficult to open. Dose reminders and compliance monitoring are not integrated.
OnDosis will resolve several of the issues with today’s main paradigm. Instead of picking up a bottle at the pharmacy, in the future patients will receive their medicine in the integrated OnDosis device.
Several studies have shown that ADHD patients have very low ability to continuously take their medicine at the right time (compliance) and to continue treatment at all (adherence). Difficulty swallowing pills was one of the most common identified barriers in treatment adherence for adolescents. ADHD drugs have a high abuse and diversion risk, with as many as 1 in 5 college students having misused or abused them. To maintain efficacy and manage side effects, monitoring of symptoms during treatment and delicate dose adjustment is necessary. OnDosis will resolve user personalization, dose titration, swallowing difficulties and monitoring of compliance.
Dose titration is a key part of initial treatment after an organ transplant, as clinicians adjust immunosuppression treatment to the characteristics of the individual patient. The complexity of the medication-taking regimen makes adherence difficult and adherence decreases over time – studies show as many as 22-30% of patients are non-adherent. Several patient groups within this population have issues swallowing tablets or capsules. OnDosis will resolve dose titration, swallowing difficulties and monitoring of compliance.
Effective treatment for severe pain exists, but there are still significant unmet patient needs. Treatment needs to be made safer – the risk for misuse of opioids is real, with as many as 21-29% of patients prescribed opioids for chronic pain misusing them. There is great variation in the dose of opioid required by individual patients and opioid selection, initial dosing, and titration must be individualized. Pill-swallowing difficulties affect somewhere between 10-40% of the adult population. The OnDosis device and companion app supports self-monitoring and feedback, which for many patients reduces pain, depression and anxiety, improving overall quality of life. OnDosis will resolve user personalization, dose titration, swallowing difficulties and monitoring of compliance.